Seven transmembrane G protein-coupled receptors (GPCRs) are often phosphorylated at the C-terminus and on intracellular loops in response to various extracellular stimuli.
Introduction
Seven transmembrane-spanning G protein-coupled receptors (GPCRs) compromise the largest known membrane protein family encoded by the human genome, and GPCRs regulate almost all known physiological processes in humans by converting a broad range of extracellular stimuli (ranging from light to hormones and neurotransmitters) to intracellular signals (Dohlman, 2015; Manglik and Kobilka, 2014; Ritter and Hall, 2009; Wisler et al., 2014) . Upon ligand binding and activation, most GPCRs 'floating' on the plasma membrane are phosphorylated at sites located on intracellular loops or C-terminal tails (Table 1) . Many different phosphorylation sites in different GPCRs have been identified, mostly by mass spectrometry or phospho-specific antibodies. By contrast, the functions of receptor phosphorylation are often established by mutagenesis both in vitro and in vivo (Bradley et al., 2016; Budd et al., 2000; Busillo et al., 2010; Jones et al., 2007) . In cells, the phosphorylation process is mediated by at least two classes of serine/threonine kinases, including the second messenger-dependent (e.g., PKA and PKC) andindependent kinases (i.e., GPCR kinases or GRKs) (Lefkowitz, 1998) . As a classical paradigm, phosphorylation of receptors by the former type of kinases is independent of ligand binding and directly uncouples the receptors from their cognate G proteins, leading to heterologous desensitization (Hausdorff et al., 1990) . In contrast, receptor phosphorylation by GRKs, a kinase family consisting of seven members, is ligand-stimulation-dependent and is followed by the recruitment of arrestin molecules to the receptor that sterically inhibit G protein coupling, initiating homologous desensitization (Gurevich et al., 2012; Pitcher et al., 1992; Tobin et al., 2008) .
The functional importance of receptor phosphorylation has been demonstrated in many aspects of GPCR regulation other than desensitization. Studies of the PKA-regulated β2-adrenergic receptor (β2AR) phosphorylation have shown that it not only decreases the coupling of β2AR to This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on March 14, 2017 molpharm.aspetjournals.org Downloaded from the Gs protein but also switches this coupling to the Gi protein (Daaka et al., 1997; Lefkowitz et al., 2002) . Receptor phosphorylation by GRKs promotes the coupling of arrestins to the activated receptors, which then mediate G protein-independent signalling. Four isoforms of arrestin have been identified: arrestin-1 and -4 are restricted to the visual system and accordingly named 'visual arrestins' (Craft et al., 1994; Wilden et al., 1986) , whereas the other two isoforms, β-arrestin-1 and -2, are ubiquitously distributed (Attramadal et al., 1992; Lohse et al., 1990) . Arrestin binding facilitates the internalization of non-visual receptors via clathrin-dependent endocytic machinery (McDonald and Lefkowitz, 2001; Shenoy and Lefkowitz, 2003) . Moreover, arrestin-mediated receptor trafficking initiates a second wave of receptor signalling via interactions with a growing list of signalling molecules, such as SRC, Raf-1, Akt, ERK1/2, PDE, and DGKs (Barki-Harrington and Rockman, 2008; Dong et al., 2016; Kumari et al., 2016; Luttrell et al., 1999; Ning et al., 2015; Reiter et al., 2012; Wang et al., 2014; Xiao et al., 2010) . In particular, activation of a single receptor, such as angiotensin II receptor (AT1aR), recruits more than 220 signalling proteins to the receptor/arrestin complexes (Xiao et al., 2010) . Given the potential multiple phosphorylation sites located on GPCRs, the possibility of a mechanism that mediates the phosphorylation pattern of the receptor such that specific signalling molecules are recruited through arrestin is intriguing.
In 2011, two seminal studies brought the barcode hypothesis of GPCR phosphorylation to light by studying two prototypic GPCRs, 2AR and M3-muscarinic acetylcholine receptor (M3-mAChR) (Butcher et al., 2011; Nobles et al., 2011) . Whereas distinct phosphorylation patterns of the 2AR induced by different GRKs are correlated with different cellular functions (Nobles et al., 2011) , M3-mAChR is differentially phosphorylated in various cells and tissues, supporting a role for receptor phosphorylation in directing physiologically relevant receptor signalling (Butcher et al., 2011) . Therefore, the phosphorylation of distinct sites on the GPCRs may constitute a barcode This article has not been copyedited and formatted. The final version may differ from this version. that dictates the downstream signalling outcomes of the receptor. Because different ligands that bind to a single receptor might induce distinct patterns of receptor phosphorylation, the pleiotropic functionalities and therapeutic importance of ligand-specific, phosphorylation/arrestin-dependent signalling have been emerging (Jean-Charles et al., 2016; Latorraca et al., 2016; Peterhans et al., 2016; Smith and Rajagopal, 2016; Xiao and Liu, 2016) . However, since there is little primary phosphorylation pattern identity among different receptors, the mechanism by which the phosphobarcode is recognized and then converted to specific signalling remains largely unknown, although many of the GPCRs share similar signalling pathways, such as arrestin-mediated ERK or SRC signalling.
Recently, using a newly developed unnatural amino acid incorporation technique combined with fluorine-19 nuclear magnetic resonance ( 19 F-NMR) spectroscopy (NeumannStaubitz and Neumann, 2016), we showed that the phosphorylation barcode of the receptor is specifically recognized by the N-terminal half of arrestin (Yang et al., 2015) . The 10 phosphatebinding sites located at the N-domain of arrestin act as sensors on the phosphorylated receptor Cterminal tail, which in theory, enables more than 1000 specific arrestin conformations for downstream signalling outcomes. Given this recent progress, we will review the current knowledge of GPCR phosphorylation, summarize the recent studies that support the barcode hypothesis, and highlight the emerging structural mechanism of GPCR phospho-coding.
Phosphorylation of the GPCR at multiple sites
Stimulus-induced GPCR phosphorylation was first reported for rhodopsin in 1972, which led to the subsequent identification and isolation of rhodopsin kinase (GRK1) (Kuhn and Dreyer, This article has not been copyedited and formatted. The final version may differ from this version. Weller et al., 1975) . A similar observation was identified in the 2AR system, where the deactivation of agonist-occupied 2AR was found to be tightly associated with receptor phosphorylation by a -adrenergic receptor kinase (ARK or GRK2) (Benovic et al., 1986; Stadel et al., 1983) . These findings identified the pivotal role of phosphorylation in the desensitization mechanism of GPCRs. Since then, 7 isoforms of GRKs, referred to as GRKs 1-7, have been identified (Pitcher et al., 1998) . GRKs 2, 3, 5, and 6 are ubiquitously expressed and serve as important determinants of phosphorylation patterns in most non-visual system GPCRs (Butcher et al., 2012; Krupnick and Benovic, 1998) . In addition to GRKs, GPCR can also be phosphorylated by second messenger-regulated kinases and some other kinases (Benovic et al., 1985; Kelly et al., 2008; Pitcher et al., 1992; Tobin, 2008) . For example, casein kinase-induced phosphorylation plays important roles for M3-mAChR and thyrotropin-releasing hormone receptor, whereas CaMKIIinduced phosphorylation has been identified in the dopamine receptor D3, GABAB receptor, and -opioid receptor (Table 1 and Table 2 ) (Budd et al., 2001; Chen et al., 2013; Guetg et al., 2010; Hanyaloglu et al., 2001; Liu et al., 2009; Torrecilla et al., 2007) . These kinases are important 'composers' of receptor phosphorylation patterns and, therefore, specifically regulate receptor functions.
The very first mutagenesis analyses of rhodopsin and 2AR determined that these receptors are phosphorylated at multiple sites (Bouvier et al., 1988; Wilden and Kuhn, 1982) . As discussed previously, the involvement of a variety of protein kinases suggests that undergoing multiple phosphorylation events might be a common phenomenon among the GPCR superfamily, and this has been confirmed by numerous studies mapping phosphorylation sites on GPCRs using different techniques and approaches. Whereas site-directed mutagenesis was considered the primary method for identifying the potential phosphorylation residues in early studies, multiple novel techniques This article has not been copyedited and formatted. The final version may differ from this version. have been developed and applied for more precise mapping of phosphorylation sites in an increasing number of GPCRs (Table 1) . For example, using mass spectrometry analysis and phospho-specific antibodies, 3 serines and 2 threonines at the C-tail of the ghrelin receptor and 14 serines and 2 threonines at the C-tail and on the third intracellular loop (ICL3) of the M3-mAChR were identified as phosphorylation sites (Bouzo-Lorenzo et al., 2016; Butcher et al., 2011) .
Furthermore, whereas the phosphorylation sites of GPCRs are primarily located at the C-tail and on the ICL3, there is increasing evidence that phosphorylation events could also occur on other cytoplasmic regions, including the first and second intracellular loops (Table 2 ) (Celver et al., 2001; Nakamura et al., 1998; Nobles et al., 2011) .
One interesting feature of GPCR phosphorylation is its dynamics and sequential fashion.
For example, the phosphorylation of the primary sites in rhosopsin permits the phosphorylation of the other residues, and this has also been observed in several other GPCRs (Ohguro et al., 1993) .
Studies of the phosphorylation profile of the D1 dopamine receptor (DRD1) indicated that although the mutation of a cluster of serines within the ICL3 resulted in severely impaired ligandinduced receptor phosphorylation and desensitization, C-terminal truncation at a selective threonine (Thr347) led to reduced receptor phosphorylation but normal arrestin-mediated desensitization (Kim et al., 2004) . This result suggested that primary phosphorylation of the specific sites on the C-tail of the DRD1 is required for secondary phosphorylation of the residues within ICL3, which leads to receptor desensitization. This type of hierarchical phosphorylation has also been described for the A3 adenosine receptor (Palmer and Stiles, 2000) and the δ-opioid receptor (Kouhen et al., 2000) , suggesting that it is a general phenomenon.
Taken together, these findings indicate that agonists promoted GPCR phosphorylation at multiple sites, including the C-tail, the ICL3, and the first and second intracellular loops. The This article has not been copyedited and formatted. The final version may differ from this version. (Ahn et al., 2004; Luttrell et al., 1999; Ning et al., 2015; Wang et al., 2014; Yang et al., 2015) . Given this similarity, it is possible that the coupling of arrestins to activated and phosphorylated receptors is nonspecific and leads to the same signalling downstream of different receptors. However, studies have shown that different GRKs regulate distinct functions of GPCRs. For instance, research on the AT1aR and V2 vasopressin receptor (V2R) showed that GRK2 and GRK3 are indispensable for agonist-dependent β-arrestin recruitment and receptor desensitization, whereas GRK5 and GRK6 are primarily responsible for β-arrestin-2-mediated ERK1/2 signalling (Kim et al., 2005; Ren et al., 2005) . These findings raised the question of whether these distinct functional outcomes are generated by signalling arising from different receptor phosphorylation events or by the activity of these GRKs towards other substrates.
Therefore, an elegant study was subsequently performed to investigate the phospho-coding of the 2AR using mass spectrometry and cellular approaches (Nobles et al., 2011) . In 2AR-expressing HEK293 cells, GRK6-dependent phosphorylation promotes β-arrestin-2-mediated ERK1/2 signalling, whereas GRK2-dependent phosphorylation functions in the opposite manner yet plays more important roles in receptor internalization. Consistent with these findings, a full agonist of 2AR stimulates robust phosphorylation at both GRK2 and GRK6 sites, whereas a -arrestinbiased ligand is able to initiate 2AR phosphorylation only at GRK6 sites. Moreover, bioluminescence resonance energy transfer (BRET) analysis showed that distinct phosphorylation patterns of 2AR induced by GRK2 or GRK6 are correlated with different -arrestin-2 conformations (Nobles et al., 2011) . Similarly, different GRK subtypes also encode specific functional capabilities and conformational changes of -arrestin-1, as shown by our recent studies.
Our data indicated that by interacting with -arresin-1, the GRK2-induced 2AR phosphorylation pattern selectively recruits clathrin, whereas the GRK-6-regulated phosphorylation pattern selectively activates SRC (Yang et al., 2015) . Collectively, these studies provide evidence that different GRKs phosphorylate distinct sites on the receptors and thereby establish a phosphorylation barcode, which in turn affects the conformation of the recruited -arrestins by changing the topology of the intracellular face of the receptor and further dictates -arrestin-related cellular functional outcomes (Fig. 1 ).
The barcode hypothesis has been supported by numerous data from studies of different types of GPCRs, including CCR7 (Zidar et al., 2009) , the free fatty acid receptor GPR120 (Prihandoko et al., 2016) , and the ghrelin receptor (Bouzo-Lorenzo et al., 2016) . For example, the phosphorylation of five residues that are clustered in two separable regions of the C-tail of GPR120 is pivotal for -arrestin-2 recruitment (Butcher et al., 2014) . Whereas the phosphorylation of residues within cluster 1 (Thr347, Thr349 and Ser350) is indispensable for Akt activation, the phosphorylation of residues within cluster 2 (Ser357 and Ser361) is specifically responsible for arrestin-mediated receptor internalization (Prihandoko et al., 2016) . Moreover, studies of subtypes of another multi-functional therapeutic target, the orexin receptor, demonstrated that phosphorylation of an additional serine/threonine cluster in the C-tail of the orexin-2 receptor establishes a phospho-barcode that is different from that of the orexin-1 receptor, enabling the orexin-2 receptor to form more stable complexes with β-arrestin and ubiquitin (Dalrymple et al., 2011; Jaeger et al., 2014) .
With increasing evidence, most of which is derived from in vitro studies, supporting the barcode hypothesis, one outstanding question is how the phosphorylation barcode contributes to the physiological responses of GPCRs. Recently, progresses have been made towards answering this question in a series of studies on M3-mAChR. By combining phosphopeptide mapping, mass spectrometry, and phospho-specific antibodies, Tobin and colleagues showed that M3-mAChR is differentially phosphorylated in three cell lines, including CHO cells transfected with M3-mAChR, mouse insulinoma (MIN6) cells, and cerebellar granule neurons that endogenously express M3-mAChR (Butcher et al., 2011; Torrecilla et al., 2007) . Accordingly, different phosphorylation patterns of three serine residues, two of which (Ser384 and Ser412) are within ICL3 and another (Ser577) is at the C-terminus of M3-mAChR, were revealed in the central nervous system, pancreas, and salivary glands of the mouse. Moreover, the phosphorylation profiles at these residues of M3-mAChR, especially at Ser577, were different in response to full or partial agonists administration (Butcher et al., 2011) . The kinases that contribute to different phosphorylation patterns and the potential roles of arrestins in these processes remain elusive; however, these findings provide compelling evidence that the phosphorylation status of M3-mAChR is liganddependent and both cell type-and tissue-specific, thus suggesting a substantial correlation between the phospho-barcode and the functional outcomes of receptor in different physiological contexts.
This article has not been copyedited and formatted. The final version may differ from this version. To understand the physiological relevance of receptor phosphorylation, a series of studies was performed using transgenic knock-in mice. Removal of the phosphorylatable sites on M3-mAChR by mutation resulted in the abolition of arrestin recruitment and arrestin-mediated receptor internalization but had little effect on Gq-dependent signalling pathways in terms of PKC activation and calcium mobilization. Intriguingly, compared with the normal mice, the transgenic mice carrying the phospho-deficient M3-mAChR mutant displayed significant deficiencies in pancreatic insulin secretion (Kong et al., 2010) , hippocampal learning and memory (Poulin et al., 2010 ) and bronchoconstriction regulation (Bradley et al., 2016) . In contrast, the transgenic mice behaved normally in terms of M3-mAChR-mediated salivary secretion and weight gain (Bradley et al., 2016) , indicating that these physiological responses are independent of M3-mAChR phosphorylation. Collectively, these data provide primary insight into the physiological roles of receptor phosphorylation. However, more animal models that harbour mutants for specific phosphorylation sites of target receptors are required to better understand the significance of barcode hypothesis in vivo and to further link distinct phosphorylation patterns of GPCRs to different physiological functions.
Taken together, these novel findings indicate that different phosphorylation patterns of GPCRs that might be generated by different kinases, potentially resembling a barcode in the intracellular regions of the receptor, could transduce specific information and dictate distinct functional outcomes (Fig. 1) . However, despite these developments and breakthroughs, it should be noted that the phosphorylation barcode hypothesis is not supported by all studies. For example, a cytoplasmic tail truncation mutant of AT1aR that cannot be phosphorylated by either GRK or PKC was shown to recruit -arrestin, albeit in a weaker manner than the wild-type receptor.
Strikingly, phosphorylation-deficient AT1aR elicits normal ERK signalling upon agonist
This article has not been copyedited and formatted. The final version may differ from this version. (DeWire et al., 2007) . Similarly, for some other GPCRs, such as luteinizing hormone receptor and the D6 chemokine receptor, phosphorylation is not necessarily required for arrestin recruitment (Galliera et al., 2004; Min and Ascoli, 2000) . Intriguingly, studies have also suggested that negatively charged amino acids located in the ICL3 or C-tail might function as phosphate mimics in these non-phosphorylated receptors and thereby interact with arrestins, contributing to GPCR regulation (Galliera et al., 2004; Gurevich and Gurevich, 2006; Mukherjee et al., 2002; Tobin, 2008) . Nevertheless, considering the relatively low sequence homology, particularly in the intracellular loops and C-terminal domains, among different receptors, it is still difficult to understand how the phospho-barcode selectively directs different arrestin functions. To provide further mechanistic insight, a detailed structural analysis of the interaction between phosphorylated receptors and arrestins is urgently needed.
Structural basis of GPCR phospho-barcoding: a flute model
Mammalian genomes encode 16 G, 5 G, and 12 G subunits (Downes and Gautam, 1999; Khan et al., 2013) . In contrast, there are only two -arrestin isoforms that are ubiquitously distributed. It is therefore unclear how arrestins decipher the phosphorylation barcode and regulate numerous GPCR functions by selectively interacting with a large repertoire of downstream signalling molecules. Early in vitro studies using limited tryptic proteolysis and mass spectrometry analysis revealed that upon binding to a phosphopeptide derived from the C-tail of V2R, both subtypes of the -arrestins undergo significant conformational changes (Nobles et al., 2007; Xiao et al., 2004) . The C-terminus of -arrestin, which harbours the clathrin-binding site and is primarily responsible for receptor endocytosis, was observed to be exposed upon activation. Moreover, a subtle difference in conformational changes was observed between the two subtypes of -arrestins, predominantly locating in the connecting region between the N-and C-domains. It was then hypothesized that arrestins are able to adopt multiple conformations, which connect to different signalling pathways (Gurevich and Gurevich, 2006) . Subsequently, structural changes in -arrestin-2 were detected using an intramolecular BRET-based biosensor upon stimulation of AT1aR, 2AR, or PTH1R by agonists (Shukla et al., 2008) . Further evidence supporting this notion came from a recent study using an improved BRET sensor with a panel of intramolecular fluorescein arsenical hairpins (FlAsH) inserted in specific loops of -arrestin-2, revealing that different -arrestin-2 conformational changes generated distinct 'conformational signatures' correlated with different downstream functions (Lee et al., 2016) .
The crystal structures of V2R phosphopeptide-bound -arrestin-1 and a fusion complex of constitutively active rhodopsin bound to a pre-activated visual arrestin were recently determined (Kang et al., 2015; Shukla et al., 2013) . In comparison to the inactive conformation, the activated arrestin molecule undergoes displacement of its C-terminus from the N-domain and an approximately 20 o twisting between its N-and C-domains that repositions several important loops, including the finger, middle, and lariat loops, and thereby allows interactions with the seventransmembrane core of the GPCR. Importantly, the interaction between -arrestin-1 and 2V2R
( modified 2AR with its C-terminus replaced by that of V2R) was recently visualized by negative stain electron microscopy, which has substantially improved our understanding of GPCR-arrestin interaction (Shukla et al., 2014) . Collectively, these studies suggest that -arrestin firstly interact with the phosphorylated C-tail of the activated receptor via its N-domain and subsequently forms tighter engagement with the transmembrane core of the receptor. These marked conformational changes of arrestin and the biphasic mechanism of GPCR--arrestin interaction shed the first light on structural information during arrestin activation. However, the crystal structure represents a static profile of only a single activated arrestin molecule, limiting any in-depth analysis of the structural changes of arrestin that correlate with differential signalling. Therefore, the detailed mechanism by which arrestins precisely transmit the phospho-coding information to downstream effectors remains to be elucidated.
To better characterize the conformational changes in arrestin and to uncover the phosphobarcoding mechanism for selective signalling, we incorporated 19 F-NMR probes at 7 potential phosphate-binding pockets to sense negatively charged interactions and at 7 other sites to monitor the conformational changes in -arrestin-1 by using unnatural amino acid 3, 5-difluorotyrosine (F2Y) incorporation (Yang et al., 2015) . We showed that -arrestin-1 interacts with different types of phosphopeptides, which were synthesized to mimic different phospho-barcodes corresponding to the C-terminus of 2AR phosphorylated by GRK2, GRK6, or PKA, through different phosphointeractions patterns correlated with selective functional outcomes. Intriguingly, whereas GRK2-phosphopeptides (GRK2pp) bind to β-arrestin-1 in a 1-4-6-7 pattern and mediate the clathrin interaction, GRK6-phosphopeptides (GRK6pp) interact with β-arrestin-1 in a 1-5 pattern and specifically elicit SRC signalling. Moreover, analyses of To further examine whether the identified arrestin-involved phospho-coding mechanism could be generally applied to many GPCR members, we performed alanine substitution of specific phosphate-binding sites residues in -arrestin-1 and tested their functionalities upon interactions with different GPCRs, including 2AR, cholecystokinin type-A receptor (CCKAR), and somatostatin receptor type 2 (SSTR2). In accordance with the in vitro data, phosphate-binding site 4 was important for the -arrestin-1/clathrin association, whereas site 5 was essential for the - 
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